Bavarian Nordic eyes opportunities in huge pox vaccine stockpiles

Several countries are currently sitting on hundreds of millions of second-generation pox vaccines in case of biological terror attacks. But people do not accept the side effects, says the CEO of Bavarian Nordic, who wants to push the company’s pox vaccine into a leading position at these emergency stores.
Bavarian Nordic CEO Paul Chaplin | Photo: Bavarian Nordic /PR
Bavarian Nordic CEO Paul Chaplin | Photo: Bavarian Nordic /PR
by christian bundgaard, translated by catherine brett

Since 2007, the Strategic National Stockpile (SNS) has stockpiled enough pox vaccines to vaccinate every single person in the US if a biological terror attack occurs. The UK has done the same.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading